I now have comprehensive information from Miller's Anesthesia, Barash's Clinical Anesthesia, and Morgan & Mikhail's to compile a thorough answer.
Complications of Regional Anaesthesia
Regional anaesthesia complications fall into two broad categories: neuraxial complications (spinal/epidural/caudal) and peripheral nerve block complications, with some complications common to both.
1. Local Anaesthetic Systemic Toxicity (LAST)
The most feared complication of any regional anaesthetic technique. It results from inadvertent intravascular injection or rapid systemic absorption exceeding safe plasma thresholds.
Mechanism
Local anaesthetics readily cross the blood-brain barrier and block voltage-gated Na⁺ channels in the CNS and cardiovascular system. Potency and lipid solubility directly correlate with toxicity risk: bupivacaine > ropivacaine/levobupivacaine > lidocaine.
CNS Manifestations (dose-dependent — Lidocaine model)
| Plasma Concentration (mg/mL) | Effect |
|---|
| 1–5 | Analgesia |
| 5–10 | Lightheadedness, tinnitus, perioral numbness |
| 10–15 | Seizures, unconsciousness |
| 15–25 | Coma, respiratory arrest |
| >25 | Cardiovascular depression |
CNS excitation (seizures) typically precedes cardiovascular collapse, but with bupivacaine, cardiac toxicity can occur at similar or even lower doses than CNS toxicity.
Cardiovascular Toxicity
- Dose-dependent slowing of cardiac conduction → prolonged PR interval, widened QRS
- Bupivacaine binds Na⁺ channels during systole and dissociates very slowly in diastole, leading to cumulative channel blockade at physiological heart rates — explaining its propensity for ventricular dysrhythmias and refractory cardiac arrest
- Vasodilation, myocardial depression, and pulmonary artery hypertension also occur
- Ropivacaine and levobupivacaine are ~30–40% less cardiotoxic than bupivacaine in animal models
Prevention
- Strict adherence to maximum dose limits
- Ultrasound guidance to visualise needle tip and local anaesthetic spread
- Aspiration before injection
- Incremental fractionated injection (test dose)
- Avoid large-volume fascial plane blocks without epinephrine (e.g., TAP blocks: max 0.25% bupivacaine ≤20–25 mL per side + epinephrine 1:200,000)
Treatment
- Stop injection immediately; call for help
- Maintain airway, oxygenation, ventilation
- Treat seizures: benzodiazepines (midazolam 1–5 mg IV) or propofol
- Intralipid (lipid emulsion 20%) — cornerstone of LAST treatment:
- Bolus: 1.5 mL/kg over 1 minute
- Infusion: 0.25 mL/kg/min for ≥10 minutes after haemodynamic stability
- ACLS as needed; avoid vasopressin, calcium channel blockers, β-blockers
- Amiodarone for ventricular dysrhythmias
- Consider cardiopulmonary bypass for refractory cases
— Barash's Clinical Anesthesia 9e, p. 3503–3504; Miller's Anesthesia 10e
2. Post-Dural Puncture Headache (PDPH)
The most common complication of neuraxial anaesthesia.
Pathophysiology
Leakage of CSF through the dural rent → reduced intracranial CSF pressure → vascular hyperaemia, traction on pain-sensitive intracranial structures, and migraine-like physiology.
Clinical Features
- Postural headache: worsens upright, relieved by lying supine (orthostatic pattern is pathognomonic)
- May be accompanied by neck stiffness, photophobia, tinnitus/muffled hearing (cochlear aqueduct connects middle ear to CSF)
- Diplopia (CN VI palsy) in severe cases → indicates urgent epidural blood patch
Incidence
- Related to needle gauge and tip design: >70% with 16G cutting needle → <1% with 25G pencil-point (Whitacre/Sprotte) needles
- Unintentional dural puncture during epidural placement: 1–1.5%; headache follows in 30–60% of these
- Higher risk: young females, parturients, previous PDPH, multiple attempts
Differential Diagnosis (important)
- Meningitis (fever, nuchal rigidity — urgent)
- Postpartum preeclampsia (hypertension)
- Cerebral venous thrombosis, subdural haematoma, stroke
- Tension/migraine/caffeine withdrawal headache
Treatment
- Conservative: bed rest, oral hydration, NSAIDs, paracetamol, opioids, caffeine (500 mg IV / 300 mg oral — short-term benefit via vasoconstriction)
- Epidural Blood Patch (EBP): definitive treatment for severe/incapacitating PDPH
- 20 mL autologous blood injected into lumbar epidural space
- ~83–92% respond to first patch; 8–17% require a second
- Indicated immediately if cranial nerve signs present
— Miller's Anesthesia 10e, p. 8877–8879; Barash's Clinical Anesthesia 9e, p. 3505
3. Epidural/Spinal Haematoma
Risk Factors
- Coagulopathy or anticoagulant therapy (most important)
- Platelet count <70,000/mm³ (risk substantially increased)
- Traumatic needle/catheter insertion
- Highly vascular epidural space
Incidence
- Extremely rare in healthy patients: ~1 in 251,463 obstetric epidurals (SCORE project)
Clinical Features
- Severe back pain (often new-onset or "different" pain)
- Persistent or progressive motor blockade beyond expected duration
- Bladder/bowel dysfunction
Management
- Urgent MRI if suspected
- Neurosurgical decompression within 6–8 hours to prevent permanent neurological deficit
- Follow ASRA guidelines for anticoagulant timing around neuraxial procedures
4. Neurological Injury
Direct Spinal Cord Injury
- Rare when procedures performed below the conus medullaris (L1–L2)
- Spinal cord syrinx formation reported when injection occurs at an unintentionally high level — pain on injection is a warning sign: stop injecting immediately
- Incidence: ~0.6/100,000 (epidural), ~3/100,000 (spinal)
Transient Neurological Symptoms (TNS)
- Back pain radiating to buttocks/legs without sensory/motor deficit, resolving within days
- Most associated with hyperbaric lidocaine (incidence up to 12%)
- Also reported with tetracaine (2%), bupivacaine (1%), mepivacaine, prilocaine
- Greatest in lithotomy position and day-case surgery
Peripheral Neuropathy
- Postpartum femoral and lateral femoral cutaneous neuropathies: ~0.92% incidence
- Associated with nulliparity and prolonged second stage — not epidural use
- Usually resolves with time; neurology follow-up advised
Anterior Spinal Artery Syndrome
- Rare ischaemic injury to anterior spinal cord following profound hypotension
- Presents with motor paralysis + loss of pain/temperature sensation but preserved proprioception
5. Total Spinal Block
A rare, life-threatening complication from excessive cephalad spread of local anaesthetic in the subarachnoid space.
Causes
- Unintentional intrathecal injection of an epidural dose
- Spinal catheter after dural puncture
- Spinal anaesthesia following failed epidural (epidural drug already in place)
Risk Factors
Obesity, short stature, spinal deformity, prior accidental dural puncture, epidural-to-spinal sequence
Features
- Rapidly ascending sensorimotor block
- Dyspnoea → respiratory failure
- Inability to phonate, dysphagia
- Profound hypotension → brainstem hypoperfusion → loss of consciousness
Treatment (supportive)
- Airway: rapid sequence intubation
- Circulation: IV fluids, vasopressors (ephedrine/phenylephrine), left lateral tilt (obstetric patient)
- Leg elevation
6. Infectious Complications
Rare with strict aseptic technique, but potentially catastrophic.
| Infection | Presentation | Urgency |
|---|
| Meningitis | Fever, headache, nuchal rigidity, photophobia | Urgent |
| Epidural abscess | Back pain, fever, neurological deficit | Emergency — surgical drainage |
| Superficial wound infection | Local erythema, discharge | Antibiotics |
ASA/ASRA aseptic standards: cap, mask (covering mouth and nose), hand wash, sterile gloves, chlorhexidine-alcohol skin prep, sterile draping.
7. Haemodynamic Complications
Hypotension
- Most common complication of spinal/epidural anaesthesia
- Due to sympathetic blockade → arterial and venous vasodilation → reduced preload and afterload
- Higher blocks (>T4) block cardiac accelerator fibres → bradycardia
Management: IV fluids, vasopressors (phenylephrine or ephedrine), ephedrine preferred in bradycardic patients
Bradycardia and Cardiac Arrest
- Occurs with high sympathetic block (T1–T4 blockade)
- Atropine, ephedrine, epinephrine as appropriate
- Rare but documented cases of cardiac arrest during spinal anaesthesia
8. Complications Specific to Peripheral Nerve Blocks
| Complication | Block at Risk | Notes |
|---|
| Pneumothorax | Interscalene, supraclavicular, paravertebral | Incidence up to 0.5–1% with landmark technique; much lower with ultrasound |
| Phrenic nerve palsy | Interscalene (100%), supraclavicular (50%) | Contraindicated with contralateral phrenic palsy or severe respiratory disease |
| Horner's syndrome | Interscalene, stellate block | Ptosis, miosis, anhidrosis — benign and transient |
| Recurrent laryngeal nerve palsy | Interscalene | Hoarseness |
| Vascular injection/haematoma | Any block near major vessels | |
| Nerve injury | Any peripheral block | Risk reduced with ultrasound guidance and nerve stimulator |
9. Allergic / Hypersensitivity Reactions
True allergy to local anaesthetics is rare (<1%). More common with ester-type agents (procaine, tetracaine, benzocaine) due to PABA metabolite formation. Amide agents (lidocaine, bupivacaine, ropivacaine) rarely cause true allergy.
- Allergy to preservatives (methylparaben, metabisulphite) is more common than allergy to the local anaesthetic itself
- Anaphylaxis managed with epinephrine, antihistamines, steroids, fluid resuscitation
Summary Table
| Complication | Mechanism | Key Management |
|---|
| LAST (CNS) | Excessive plasma conc. → Na⁺ channel block | Benzodiazepines, airway support |
| LAST (CVS) | Slow-dissociation Na⁺ channel block (bupivacaine) | Intralipid 20%, ACLS, avoid vasopressin/β-blockers |
| PDPH | CSF leak → traction/hyperaemia | Blood patch (20 mL autologous blood) |
| Epidural haematoma | Vascular injury + coagulopathy | Emergency MRI + decompressive surgery |
| Total spinal | Excessive intrathecal spread | Intubation, vasopressors |
| Neurological injury | Direct trauma, ischaemia, toxicity | Prevention; neurological rehabilitation |
| Hypotension | Sympathetic blockade | Fluids, vasopressors, lateral tilt |
| Infection | Breach of asepsis | Antibiotics; surgical drainage if abscess |
| Pneumothorax | Needle near pleura | Chest drain if significant |
Sources: Miller's Anesthesia 10e (Chapter 58 & Chapter 22); Barash, Cullen & Stoelting's Clinical Anesthesia 9e (Chapter 22 & 14); Morgan & Mikhail's Clinical Anesthesiology 7e (Chapter on neuraxial anaesthesia)